Surf Wiki
Save to docs
geography/china

From Surf Wiki (app.surf) — the open knowledge base

Sinopharm Group

Chinese biotechnology company

Chinese biotechnology company

FieldValue
nameSinopharm Group
logoSinopharm Group logo.png
logo_size250px
logo_altlogo of Sinopharm Group (same as China National Pharmaceutical Group), with bilingual name on the right
logo_captionlogo of Sinopharm Group (same as China National Pharmaceutical Group), with bilingual name on the right
typepublic
traded_as
ISINCNE100000FN7
foundation
founderChina National Pharmaceutical Group
locationSinopharm Plaza
location_cityShanghai
location_countryChina
key_people
area_servedChina
industryPharmaceutical
revenue
revenue_year2015
operating_income
income_year2015
net_income
net_income_year2015
assets
assets_year2015
equity
equity_year2015
parentSinopharm Industrial Investment
subsidSinopharm CNMC
ownerSinopharm Industrial Investment (56.79%)
footnotesin a consolidated basis; equity and profit excluded minority interests; in Hong Kong Financial Reporting Standards

Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.

Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.

Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list.

COVID-19 Vaccine development

Main article: Sinopharm BIBP COVID-19 vaccine

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. The BIBP vaccine shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19.

Peer-reviewed results published in JAMA of Phase III trials in United Arab Emirates and Bahrain showed that the BIBP vaccine is 78.1% effective against symptomatic cases and 100% against severe cases (21 cases in vaccinated group vs. 95 cases in placebo group). In December 2020, the UAE previously announced interim results showing 86% efficacy. While mRNA vaccines showed higher efficacy of over 90%, those present distribution challenges for some nations as they require deep-freeze facilities and trucks. BIBP-CorV could be transported and stored at normal refrigerated temperatures.

The BIBP vaccine is being used in vaccination campaigns by certain countries in Asia, Africa, South America, and Europe. Sinopharm was expected to produce one billion doses of the BIBP vaccine in 2021. On 7 May 2021, the World Health Organization approved the vaccine for use in COVAX.

References

References

  1. (25 April 2016). "2015 Annual Report". Hong Kong Stock Exchange.
  2. (2009-07-29). "China's Sinopharm gets OK for $1 bln HK IPO". Reuters.
  3. "Sinopharm Group".
  4. (January 2021). "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial". The Lancet. Infectious Diseases.
  5. (10 May 2021). "The Sinopharm COVID-19 vaccine: What you need to know". World Health Organization.
  6. (5 June 2021). "Coronavirus: Vietnam approves Sinopharm's vaccine, but will people take it?". South China Morning Post.
  7. (16 June 2021). "What we now know about the efficacy of China's Covid-19 vaccines". Quartz.
  8. (2020-11-19). "China Sinopharm's coronavirus vaccine taken by about a million people in emergency use". Reuters.
  9. (2021-04-26). "How the Sinopharm Vaccine Works". The New York Times.
  10. (May 26, 2021). "Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial". JAMA.
  11. (9 December 2020). "UAE: Ministry of Health announces 86 per cent vaccine efficacy".
  12. (2020-12-09). "China State-Backed Covid Vaccine Has 86% Efficacy, UAE Says". Bloomberg.com.
  13. (2020-12-31). "China gives its first COVID-19 vaccine approval to Sinopharm". Reuters.
  14. Turak, Natasha. (2021-01-18). "The UAE is on track to have half its population vaccinated by the end of March".
  15. Dawn.com. (2021-02-02). "PM Imran kicks off Pakistan's Covid-19 vaccination drive".
  16. (2021-01-24). "Sisi says Egypt to begin COVID-19 vaccinations on Sunday". [[Reuters]].
  17. Dumpis, Toms. (2021-01-27). "Morocco Receives Half a Million Doses of Chinese Sinopharm Vaccine".
  18. (2021-02-18). "Zimbabwe starts administering China's Sinopharm vaccines".
  19. (25 March 2021). "Argentina autoriza la vacuna china Sinopharm para mayores de 60 años".
  20. Aquino, Marco. (2021-02-10). "'The best shield': Peru launches inoculation drive with Sinopharm vaccine". Reuters.
  21. "Bolivia begins inoculation with Sinopharm jabs {{!}} The Star".
  22. (20 January 2021). "Serbia Becomes First European Nation To Use China's Sinopharm Vaccine". Radio Free Europe/Radio Liberty.
  23. (2021-02-24). "Hungary first EU nation to use China's Sinopharm vaccine against COVID".
  24. (2021-03-15). "Belarus begins COVID-19 vaccinations with Chinese shots".
  25. (2021-02-05). "Which companies will likely produce the most COVID-19 vaccine in 2021?".
  26. Taylor, Adam. (7 May 2021). "WHO grants emergency use authorization for Chinese-made Sinopharm coronavirus vaccine". [[The Washington Post]].
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

companies-listed-on-the-hong-kong-stock-exchange companies-based-in-shanghai companies-owned-by-the-central-government-of-china pharmaceutical-companies-of-china chinese-brands fosun-international pharmaceutical-companies-established-in-2003 retail-companies-of-china chinese-companies-established-in-2004 h-shares privatization-in-china
Want to explore this topic further?

Ask Mako anything about Sinopharm Group — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report